Artfarma Spółka z Ograniczoną Odpowiedzialnością (KRS 0000299643, NIP 7393669435) is a Polish company, headquartered in Łódź, Łódzkie voivodeship. ARTFARMA operates in: Dispensing chemist in specialised stores (PKD 47.73.Z). Industry: Retail trade. The company has been listed in the National Court Register since February 20, 2008. ARTFARMA's most recently reported net revenue was 9.4 M PLN for 2024.
Negative equity
Negative equity in 5 of 5 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Artfarma
Identity
- Name
- Artfarma Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- February 20, 2008
- Registry status as of
- June 8, 2026
- Latest entry
- June 8, 2026
- Founding act
- 12.02.2008R. NOTARIUSZ ANNA ZAJĄC, KANCELARIA NOTARIALNA W OLSZTYNIE, REP.A NR 1508/2008
Articles of association history (7)
- February 12, 2008: 12.02.2008R. NOTARIUSZ ANNA ZAJĄC, KANCELARIA NOTARIALNA W OLSZTYNIE, REP.A NR 1508/2008
- June 10, 2010: 10.06.2010R. NOTARIUSZ ANNA ZAJĄC, KANCELARIA NOTARIALNA W OLSZTYNIE, REP.A NR 5238/2010 - ZMIENIONO § 9 UST.1
- January 12, 2011: 12.01.2011 R., NOTARIUSZ GABRIELA MARZINEK. KANCELARIA NOTARIALNA W ŁOMIANKACH, REP. A NR 128/2011 - ZMIENIONO: § 8, § 9, § 10, § 11, § 13, § 16, § 21, § 22.
- March 11, 2011: 11.03.2011R. - NOTARIUSZ ANNA ZAJĄC, KANCELARIA NOTARIALNA W OLSZTYNIE, REP.A NR 2053/2011 - ZMIENIONO §8, §19 I §21 UMOWY SPÓŁKI
- March 8, 2016: 08.03.2016R., NOTARIUSZ ANNA ZAJĄC, KANCELARIA NOTARIALNA W OLSZTYNIE, REP. A NR 1685/2016 ZMIENIONO: §21 UST.2
- October 29, 2019: 29.10.2019R. I 20.12.2019R. - NOTARIUSZ BARTŁOMIEJ JANICKI, KANCELARIA NOTARIALNA W ALEKSANDROWIE ŁÓDZKIM, REP. A NR 7453/2019, REP.A NR 8604/2019 - ZMIENIONO §11 UST.2; §16, §18 UST.5, §19, §21 UMOWY
- September 20, 2024: AKT NOTARIALNY Z DNIA 20.09.2024R., REP. A NR 3970/2024, NOTARIUSZ BARTŁOMIEJ JANICKI, KANCELARIA NOTARIALNA W ALEKSANDROWIE ŁÓDZKIM, PRZYJĘCIE NOWEJ TREŚCI UMOWY SPÓŁKI
Activities
Main activity
47.73.ZDispensing chemist in specialised stores
Other activities
Address and contact
- Address
- UL. KINGA C. GILLETTE, 11, 94-406, ŁÓDŹ, POLSKA
- Voivodeship
- ŁÓDZKIE
- District
- ŁÓDŹ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-83461-94992-GIWAS-27
Risk and payment profile - Artfarma
Credibility rating
1 / 100
Very poor credibility
Insolvency risk
Very high
Significant formal threat
Closure risk
21
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
8
8/18 yrs
Board changes
7
7/18 yrs
PKD changes
4
4/18 yrs
Name changes
0
0/18 yrs
Data from 18 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: E (1/100)
Trend: stable (0.0 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2018–2024
Current: 83.1 K PLN
Safe: 8.3 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Artfarma
Founded
February 20, 2008
18 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
ŁÓDŹ
ŁÓDZKIE
Primary PKD
47.73.Z
Dispensing chemist in specialised stores
Share capital
751.5 K PLN
7,515 shares total
Shareholders
1
shareholder
Board
3 people
Filed years
5 years
2018–2024 · profitable: 0/5
Registry entries
57
latest: June 8, 2026
Risk signals
Revenue
9.4 M PLN
2024
Net profit
-1.1 M PLN
2024
Assets
30.7 M PLN
2024
Equity
-5.2 M PLN
2024
EBITDA
-80.6 K PLN
2024
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Artfarma.
No ratings
Related articles
News
Ambra in 2026: PLN 48.1 m capex (+212%), PLN 1.10 dividend three years running, Cydr Lubelski plus Romanian Zarea as the premium engine
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8 m of revenue and PLN 49.0 m of net profit, while raising capex by 212% to PLN 48.1 m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9 m acquisition of a Romanian company. Despite the aggressive investment cycle the board keeps a PLN 1.10 dividend per share for the third year running (~5.9% yield).
News
Answear in 2026: first full year without MCI, PLN 9.3 m net profit, but the supervisory board cuts the 2026 EBITDA target from PLN 100 m to PLN 90 m
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7 bn (+13% YoY), EBITDA of PLN 56 m (+63%) and net profit of PLN 9.3 m - a return to the black after a PLN 10 m loss in 2024. Poland grew +31%, but CEE was under FX pressure (hryvnia -11% vs PLN), and a weak Q4 (EBITDA -71% YoY) forced the supervisory board to cut the 2026 EBITDA target from PLN 100 m to PLN 90 m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
